Landscapes / Companies
Shandong New Time Pharmaceutical Co., LTD not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 in Phase 3
2 in Phase 2
Drugs
11
in active trials · 17 in all
Trials
14 active
26 since 2021
Drugs11
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Phase 2/3 | 30 Dec 2027Phase 2/3 trial completes | |||
| How it works | An antibody | ||||
| Next date | 30 Dec 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Cervical Cancer, Cancer of Unknown Primary Site | ||||
| Open drug page | |||||
Valsartan Oral Solutionnot checked |
Angiotensin 2 receptor blocker |
Phase 3 | Dec 2027Phase 3 trial completes | ||
| How it works | Blocks the effect of angiotensin II | ||||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
F182112not checked |
— |
Phase 3 | 20 May 2028Phase 2 trial completes | ||
| Next date | 20 May 2028 · Phase 2 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM) and 1 more | ||||
| Open drug page | |||||
— |
Phase 3 | 1 Aug 2028Phase 3 trial completes | |||
| Next date | 1 Aug 2028 · Phase 3 trial completes | ||||
| Also tested for | Type 2 Diabetes (T2DM) | ||||
| Open drug page | |||||
Cetirizine Hydrochloride Injectionnot checked |
Histamine-1 receptor antagonist |
Phase 3 | — | ||
| Also tested for | Acute Urticaria | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2026Phase 2 trial completes | |||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Colorectal Adenoma | ||||
| Open drug page | |||||
— |
Phase 2 | Feb 2027Phase 2 trial completes | |||
| Next date | Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Peptic Ulcer Bleeding | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors (Phase 1) | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2028Phase 1 trial completes | |||
| Next date | Jun 2028 · Phase 1 trial completes | ||||
| Also tested for | Patients With Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Malignant Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Malignancies | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 6 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021